1.Discussions on setbacks and countermeasures of medical devices clinical trials in China
Huacheng YAN ; Xiaoling DENG ; Xiaohui ZENG ; Lei SHI
Chinese Journal of Hospital Administration 2014;30(5):362-365
By means of literature review of existing laws and regulations,an analysis was made on main setbacks found in the clinical trials and regulation of medical devices in China.The authors proposed to enact and improve such laws and regulations as soon as possible.
2.Correlation between CYP2J2 gene polymorphism and coronary heart disease in Chinese Han population and effects of CYP2J2 geneover-expressionon aortic smooth muscle cells of ApoE-/-mice
Rui LI ; Jian QIU ; Lei SHI ; Yuan ZHANG ; Huacheng YAN ; Yunjun RUAN ; Hua XIAO
The Journal of Practical Medicine 2015;31(23):3831-3836
Objective To investigate the relationship between CYP2J2*7 mutation(G-76T) and coronary heart disease (CHD) in Chinese Hanpopulation and to study the effects of CYP2J2 geneover-expressionon the proliferation and migrationof aortic smooth muscle cells of ApoE-/- mice. Methods CYP2J2*7 genotype was detectedin 500 patients with CHD and 478 controlsubjects by the Polymerase Chain Reaction-Restriction Frag-ment Length Polymorphism (PCR-RFLP). Culturedaortic smooth muscle cells of ApoE-/- mice were divided into control group, sham transfectiongroup and CYP2J2 over-expression group. Cell proliferation and migration were investigated after CYP2J2 over-expressionby MTS and Transwell assay. Results The frequency of CYP2J2*7 in CHD group was significantly higher than that incontrol group (10.00% vs. 6.49%, P = 0.046). Same is the case in female cases(P = 0.026). Compared with these of aortic smooth muscle cells incontrol group and sham trans-fectiongroup, the cell proliferation in 24, 48, 72 h, and the cell migration in 48 h after CYP2J2 over-expression in CYP2J2 group were significantly suppressed. Conclusions CYP2J2*7 mutation might increase the risk of CHD in Chinese Han population. CYP2J2 over-expression can suppress the proliferation and migration of aortic smooth muscle cells and CYP2J2 might have the effect of anti-atherosclerosis.
3.Development of Vital Signal Monitoring System Based on Accelerometer.
Jian CEN ; Xingliang JIN ; Sanchao LIU ; Huacheng LUO ; Nong YAN ; Xianliang HE ; Yumei MA ; Hanyuan LUO ; Jie QIN ; Yinbing YANG
Chinese Journal of Medical Instrumentation 2023;47(6):602-607
OBJECTIVE:
Reduce the number of false alarms and measurement time caused by movement interference by the sync waveform of the movement.
METHODS:
Vital signal monitoring system based on motion sensor was developed, which collected and processed the vital signals continuously, optimized the features and results of vital signals and transmitted the vital signal results and alarms to the interface.
RESULTS:
The system was tested in many departments, such as digestive department, cardiology department, internal medicine department, hepatobiliary surgery department and emergency department, and the total collection time was 1 940 h. The number of false electrocardiograph (ECG) alarms decreased by 82.8%, and the proportion of correct alarms increased by 28%. The average measurement time of non-invasive blood pressure (NIBP) decreased by 16.1 s. The total number of false respiratory rate measurement decreased by 71.9%.
CONCLUSIONS
False alarms and measurement failures can be avoided by the vital signal monitoring system based on accelerometer to reduce the alarm fatigue in clinic.
Humans
;
Monitoring, Physiologic
;
Electrocardiography
;
Arrhythmias, Cardiac
;
Blood Pressure
;
Accelerometry
;
Clinical Alarms